Publication

Abstract : The escalating pandemic of coronavirus disease 2019 (COVID-19) has posed a multitude of challenges for pediatric neurologists. These range from managing children with COVID-19 presenting with neurological involvement to diagnosing COVID-19 in children presenting with isolated neurological manifestations and providing a continuum of care to children with pre-existing or newly diagnosed neurological disorders during this difficult time. The spectrum of neurological manifestations of COVID-19 continues to evolve with identification and reporting of various neurological symptoms, more commonly in adults as compared to children. Some of the common reported neurological manifestations pertaining to central nervous system in adults are dizziness, headache, encephalopathy, cerebro-vascular events, olfactory and gustatory dysfunction.[1] The peripheral nervous system manifestations described are Guillain-Barre syndrome and its variants and skeletal muscle injury.